Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Methotrexate Discontinuation on PCV20 Immunogenicity in Autoimmune Rheumatic Diseases
NCT07242092Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 20 in pneumococcal disease, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jun 2026; status: recruiting.
02
Drugs
Prevnar 20
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT07242092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242092.